Roboearth – Lifestyle
Author:
Orchestra BioMed Holdings, Inc.
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
May 6, 2026
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
April 30, 2026
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
April 23, 2026
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026